The European Medicines Agency (EMA) recently discussed, and is currently discussing, for the first time, persistent sexual dysfunction from SSRI / SNRI and the possibility of adding indications on drug labels.
The EMA seems to have been driven in particular by the Citizen Petition written by David Healy and undersigned by all researchers who have so far been interested in investigating the problem in the medical literature.
The EMA has asked us with PSSD to fill out a short questionnaire with name and surname, through David Healy.
These are the essential steps:
1- compile report on Rxisk: https://rxisk.org/experiencing-a-drug-side-effect/
2- send an email to Healy giving the availability to authenticate with name and surname (and be contacted by the EMA if necessary): david.healy@rxisk.org
3- Healy will answer attaching another short questionnaire to fill in with name and surname, requested by the EMA.
The EMA must receive them BY THE END OF DECEMBER.
ps. David Healy updates by email those with PSSD who have completed the Rxisk report.